Families pay thousands for an unproven autism treatment. Researchers say we need ethical guidelines for marketing the tech

Los Angeles TimesThursday, October 30, 2025 at 10:00:00 AM
NegativeHealth
Families pay thousands for an unproven autism treatment. Researchers say we need ethical guidelines for marketing the tech
Families are spending thousands of dollars on a technology from a Southern California company that claims to treat autism, but researchers are raising concerns about the lack of evidence supporting its effectiveness. This situation highlights the urgent need for ethical guidelines in marketing such treatments, as vulnerable families may be misled into investing in unproven solutions. It's crucial for consumers to be informed and for regulations to ensure that only evidence-based therapies are promoted.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Latest from Health
Study Finds Evidence That Text-Based Therapy Eases Depression
PositiveHealth
A recent study has shown that text-based therapy can significantly alleviate symptoms of depression, offering a promising alternative for those who may not have access to traditional therapy. This finding is important as it highlights the potential of digital solutions in mental health care, making support more accessible to a wider audience. With the rise of technology in our daily lives, this approach could revolutionize how we think about and treat mental health issues.
Novo Nordisk launched a bid valued at up to $9 billion for obesity-drug developer Metsera, hoping to trump an already agreed-on deal Pfizer made for the U.S. company
PositiveHealth
Novo Nordisk has made a significant move by launching a bid of up to $9 billion for Metsera, a developer of obesity drugs. This bid comes as a direct challenge to Pfizer, which has already secured a deal for the same company. The competition highlights the growing importance of obesity treatments in the pharmaceutical market, and Novo Nordisk's strong portfolio with drugs like Ozempic and Wegovy positions it well to potentially lead in this space. This development is crucial as it could reshape the landscape of obesity treatment and influence market dynamics.
Health Care Roundup: Market Talk
NeutralHealth
In the latest Health Care Roundup, insights on major players like Pfizer and Haleon are discussed, providing a snapshot of current market trends. This matters as it helps investors and stakeholders understand the dynamics of the health care sector, which is crucial for informed decision-making.
Casey Means, Surgeon General Nominee, Goes Into Labor Ahead of Senate Hearing
NeutralHealth
Dr. Casey Means, the nominee for Surgeon General, unexpectedly went into labor just before her scheduled Senate hearing. This development has led to the postponement of the hearing, highlighting the challenges faced by women in high-profile positions, especially during significant life events. It raises awareness about the balance between professional responsibilities and personal milestones.
Maine network ends primary care after losing Medicaid due to Trump defunding Planned Parenthood
NegativeHealth
A network of medical clinics in Maine is set to close its primary care services due to cuts in Medicaid funding linked to the Trump administration's defunding of Planned Parenthood. This closure is significant as it directly impacts low-income residents who rely on these clinics for essential healthcare services, highlighting the ongoing debate over healthcare access and reproductive rights in the U.S.
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
PositiveHealth
The FDA is taking significant steps to expedite the approval process for cheaper copycat drugs, which could greatly benefit patients by making essential medications more affordable. This move is crucial as it aims to increase competition in the pharmaceutical market, potentially lowering prices and improving access to necessary treatments for many individuals. By streamlining the approval process, the FDA is addressing a pressing issue in healthcare, ensuring that more people can access the medications they need without financial strain.